Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Revenue (2021 - 2025)

PAVmed (PAVM) has 5 years of Revenue data on record, last reported at $5000.0 in Q3 2025.

  • For Q3 2025, Revenue changed N/A year-over-year to $5000.0; the TTM value through Sep 2025 reached $29000.0, changed N/A, while the annual FY2024 figure was $3.0 million, 22.15% up from the prior year.
  • Revenue reached $5000.0 in Q3 2025 per PAVM's latest filing, down from $6000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.0 million in Q4 2023 and bottomed at -$4000.0 in Q1 2021.
  • Average Revenue over 5 years is $342866.7, with a median of $166000.0 recorded in 2023.
  • Peak YoY movement for Revenue: skyrocketed 4825.0% in 2022, then tumbled 99.39% in 2025.
  • A 5-year view of Revenue shows it stood at $300000.0 in 2021, then plummeted by 62.67% to $112000.0 in 2022, then surged by 836.61% to $1.0 million in 2023, then tumbled by 99.05% to $10000.0 in 2024, then tumbled by 50.0% to $5000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $5000.0 in Q3 2025, $6000.0 in Q2 2025, and $8000.0 in Q1 2025.